Answers are grounded in this paper and cite their sources.
Background: Congenital Hypogonadotropic Hypogonadism (CHH) is a condition characterized by deficient secretion of gonadotropin-releasing hormone (GnRH), leading to impaired reproductive function and male infertility. The role of mRNA-7a2 in gene expression regulation and its potential impact on CHH and male infertility is crucial but not well understood. Objective: To investigate the significance of mRNA-7a2 loss in CHH and its association with male infertility. Methods: This study included 100 participants, 50 with CHH and 50 healthy controls. Comprehensive clinical evaluations, hormone level assessments, and semen analysis were conducted. Blood samples were collected for serum GnRH, LH, FSH, and testosterone measurements using immunoassay techniques. Semen analysis followed WHO guidelines. Genetic testing involved next-generation sequencing to identify mutations in the mRNA-7a2 gene. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot analyses were performed on testicular biopsy samples to measure mRNA-7a2 expression and protein levels. Data were analyzed using SPSS version 25.0. Results: CHH patients showed significantly lower levels of serum GnRH (4.3 ± 1.2 pg/mL), LH (1.8 ± 0.5 IU/L), FSH (2.1 ± 0.7 IU/L), and testosterone (150 ± 35 ng/dL) compared to controls (p < 0.001). Sperm count (12.5 ± 3.8 million/mL), motility (22.4 ± 7.1%), and morphology (15.3 ± 4.6%) were also significantly reduced (p < 0.001). mRNA-7a2 expression was significantly lower in CHH patients (ΔCt 7.5 ± 1.8) than controls (ΔCt 3.2 ± 0.9) (p < 0.001). Protein levels of mRNA-7a2, SOX9, and Dmrt1 were significantly lower in CHH patients (p < 0.001). Genetic analysis identified several mRNA-7a2 mutations in CHH patients but not in controls. Conclusion: The loss of mRNA-7a2 is significantly associated with CHH and male infertility, affecting hormone levels and spermatogenesis. Targeting mRNA-7a2 may offer new therapeutic strategies for managing CHH and improving male reproductive health.
No takes yet. Share an insight, caveat, or question.
Talib et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: